JP2001501929A5 - - Google Patents

Download PDF

Info

Publication number
JP2001501929A5
JP2001501929A5 JP1998516329A JP51632998A JP2001501929A5 JP 2001501929 A5 JP2001501929 A5 JP 2001501929A5 JP 1998516329 A JP1998516329 A JP 1998516329A JP 51632998 A JP51632998 A JP 51632998A JP 2001501929 A5 JP2001501929 A5 JP 2001501929A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998516329A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001501929A (ja
Filing date
Publication date
Priority claimed from PL96316416A external-priority patent/PL185442B1/pl
Application filed filed Critical
Publication of JP2001501929A publication Critical patent/JP2001501929A/ja
Publication of JP2001501929A5 publication Critical patent/JP2001501929A5/ja
Pending legal-status Critical Current

Links

JP10516329A 1996-10-03 1997-10-03 コロストリニン、およびその使用方法 Pending JP2001501929A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL316416 1996-10-03
PL96316416A PL185442B1 (pl) 1996-10-03 1996-10-03 Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
PCT/GB1997/002721 WO1998014473A1 (en) 1996-10-03 1997-10-03 Colostrinin, and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008031513A Division JP2008174561A (ja) 1996-10-03 2008-02-13 コロストリニン、およびその使用方法

Publications (2)

Publication Number Publication Date
JP2001501929A JP2001501929A (ja) 2001-02-13
JP2001501929A5 true JP2001501929A5 (https=) 2005-05-12

Family

ID=20068412

Family Applications (2)

Application Number Title Priority Date Filing Date
JP10516329A Pending JP2001501929A (ja) 1996-10-03 1997-10-03 コロストリニン、およびその使用方法
JP2008031513A Pending JP2008174561A (ja) 1996-10-03 2008-02-13 コロストリニン、およびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008031513A Pending JP2008174561A (ja) 1996-10-03 2008-02-13 コロストリニン、およびその使用方法

Country Status (18)

Country Link
US (2) US6852700B1 (https=)
EP (1) EP0932623A1 (https=)
JP (2) JP2001501929A (https=)
KR (2) KR20050046766A (https=)
CN (2) CN1131712C (https=)
AR (1) AR013612A1 (https=)
AU (1) AU4565197A (https=)
BR (1) BR9712259A (https=)
CA (1) CA2266859C (https=)
CZ (1) CZ298215B6 (https=)
GB (1) GB2333453B (https=)
HU (1) HUP9904368A3 (https=)
IL (1) IL129211A (https=)
PL (1) PL185442B1 (https=)
RU (1) RU2217152C2 (https=)
TR (1) TR199901022T2 (https=)
WO (1) WO1998014473A1 (https=)
ZA (1) ZA978885B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
BR9910725A (pt) 1998-05-27 2001-01-30 Gemma Biotechnology Ltd Indução de proteìnas e peptìdeos antibióticos por proteìnas lait/s cd14
ATE322275T1 (de) * 1998-06-10 2006-04-15 Albert B Crum Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems
GB9813031D0 (en) * 1998-06-16 1998-08-12 Regen Biotech Limited Dietary supplement
GB9912852D0 (en) * 1999-06-02 1999-08-04 Regen Therapeutics Plc Peptides
US6903068B1 (en) * 1999-08-17 2005-06-07 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
US6852685B1 (en) * 1999-08-17 2005-02-08 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
AU7061700A (en) 1999-08-17 2001-03-13 University Of Texas System, The Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
ATE374810T1 (de) * 1999-08-17 2007-10-15 Univ Texas Verwendung von colostrinin, dessen peptidbestandteile und deren analoga zur förderung der neuronalen zelldifferenzierung
US7119064B2 (en) 1999-08-17 2006-10-10 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
AU6919700A (en) * 1999-08-17 2001-03-13 Regen Therapeutics Plc Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
GB0001825D0 (en) * 2000-01-26 2000-03-22 Regen Therapeutics Plc Peptides
AU2000269179A1 (en) * 2000-08-17 2002-02-25 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promoteneural cell differentiation
AU2000267883A1 (en) * 2000-08-17 2002-02-25 Regen Therapeutics Plc Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
WO2002013850A1 (en) * 2000-08-17 2002-02-21 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
GB0029777D0 (en) * 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
HUP0200172A2 (hu) * 2002-01-15 2003-11-28 András Bertha Eljárás tumorellenes hatóanyag kinyerésére
US20050042300A1 (en) * 2002-10-22 2005-02-24 Istvan Boldogh Use of colostrinin, constituent peptides thereof, and analogs thereof as inhibitors of apoptosis and other cellular damage
AU2004220313B2 (en) 2003-03-11 2011-06-02 Regen Therapeutics Plc Purification of peptides from colostrum
CN1313487C (zh) * 2003-06-10 2007-05-02 天津商学院 具有抗菌作用的免疫活性肽(Trpi)
WO2005041680A2 (en) * 2003-11-03 2005-05-12 Advanced Protein Systems A novel colostral fractionation process
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US20070212367A1 (en) * 2006-03-13 2007-09-13 Keech Andrew M Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions
GB2436328A (en) * 2006-03-22 2007-09-26 Regen Therapeutics Plc Peptide derived from colostrinin
US20110098216A1 (en) * 2009-10-22 2011-04-28 Regen Therapeutics Plc Therapeutic uses of colostrinin
ITMI20111460A1 (it) * 2011-07-29 2013-01-30 Bionest Ltd Composizioni per la terapia adiuvante dell'anoressia comprendenti anticorpi, fattori di crescita e citochine isolati dal colostro dei mammiferi
DK2797609T3 (en) 2011-12-30 2017-01-09 Innomed S A COMBINING growth factors, cytokines, anti-bacterial / ANTIVIRALS FACTORS STEM CELL-STIMULATING FACTORS, complement C3A / C4A, immunoglobulins, and chemotactic factors
WO2013098331A1 (en) 2011-12-30 2013-07-04 Bionest Ltd. Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, and chemotactic factors
ITMI20112433A1 (it) * 2011-12-30 2013-07-01 Bionest Ltd Composizioni per la terapia orale adiuvante dell'anoressia comprendenti anticorpi, antibatterici, fattori di crescita e citochine
GB201205856D0 (en) 2012-04-02 2012-05-16 Randall Jeremy A P Food supplement to support brain function
PL235821B1 (pl) * 2014-11-04 2020-11-02 Geo Poland Spolka Z Ograniczona Odpowiedzialnoscia Wysokoprolinowy kompleks peptydowy do zastosowania w profilaktyce i wspomaganiu leczenia zaburzeń i stanów wymagających podwyższania i/lub modulacji poziomu neurotropowego czynnika pochodzenia mózgowego jako oznaczonego w osoczu krwi biomarkera i zawierający go preparat
US10621688B2 (en) 2015-01-30 2020-04-14 Hewlett-Packard Development Company, L.P. M-ary cyclic coding
US12263192B2 (en) 2019-02-26 2025-04-01 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE90569T1 (de) 1988-04-19 1993-07-15 Biotest Pharma Gmbh Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
JPH05163160A (ja) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
JP3174611B2 (ja) * 1992-02-28 2001-06-11 明治乳業株式会社 免疫賦活組成物
US5645834A (en) 1992-08-28 1997-07-08 Immuno-Dynamics, Inc. Method and product for treating failure of passive transfer and improving milk production in bovine species
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
DE4337654C2 (de) * 1993-11-04 1996-08-08 Biotest Pharma Gmbh Verwendung boviner Kolostralmilch von nicht mit Viren hyperimmunisierten Tieren als Leberschutzpräparat
JP4112021B2 (ja) * 1994-02-16 2008-07-02 明治乳業株式会社 乳酸菌を用いた免疫賦活剤
RU2062109C1 (ru) * 1994-11-28 1996-06-20 Товарищество с ограниченной ответственностью "Старк" Способ получения иммунного препарата
AU6641896A (en) 1995-08-07 1997-03-05 New England Medical Center Hospitals, Inc., The Infant formula and infant formula additives
DE19619990A1 (de) 1996-05-17 1997-11-20 Charlotte Adler Verfahren zur Herstellung von Kolostralmilchprodukten sowie deren Verwendung
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2002512702A5 (https=)
JP2000501771A5 (https=)
JP2000501599A5 (https=)
JP2000501018A5 (https=)
JP2000500076A5 (https=)
JP2001503155A5 (https=)
JP2000500055A5 (https=)
JP2000500026A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2000500874A5 (https=)
JP2000510734A5 (https=)
JP2000503845A5 (https=)
JP2000502485A5 (https=)
JP2000502425A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000507952A5 (https=)
JP2000501876A5 (https=)
JP2000507574A5 (https=)
JP2001501929A5 (https=)
JP2000501744A5 (https=)